Latest Breaking News On - இகுத் - Page 4 : comparemela.com

CSIR-IICT, Lee Pharma in licensing agreement for synthesis of 2-DG CSIR-IICT, Lee Pharma in licensing agreement for synthesis of 2-DG 09 June 2021 | News Lee Pharma will manufacture and commercialise the 2-DG sachets from their formulation facility located at SEZ, Duvvada www.shutterstock.com shIndian Institute of Chemical Technology, (IICT), a constituent laboratory of CSIR and Lee Pharma, an integrated pharmaceutical company, based in Hyderabad have entered into a non-exclusive licensing agreement for the synthesis of 2-Deoxy-D-Glucose (2-DG). Recently, 2-DG developed by DRDO and Dr Reddy’s Laboratories has received approval for use in COVID-19 patients. It has been found to help speed up recovery and reduce oxygen dependence and Dr Reddy’s Laboratories has launched the drug in the form of sachets.

Andhra pradeshNew delhiSrivari chandrashekarLee pharmaIndian institute of chemical technologyIndian instituteChemical technologyLee pharmaஆந்திரா பிரதேஷ்புதியது டெல்ஹிலீ பார்மாஇந்தியன் நிறுவனம் ஆஃப் இரசாயன தொழில்நுட்பம்இந்தியன் நிறுவனம்இரசாயன தொழில்நுட்பம்